Clinical Impact of Physical Activity and Cough on Disease Progression in Fibrotic Interstitial Lung Disease
Authors:
- Tobias VeitTVTobias Veit
- Michaela BarnikelMBMichaela Barnikel
- Nikolaus KneidingerNKNikolaus Kneidinger
- Dieter MunkerDMDieter Munker
- Paola ArnoldPAPaola Arnold
- Jürgen BartonJBJürgen Barton
- Alexander CrispinACAlexander Crispin
- Katrin MilgerKMKatrin Milger
- Jürgen BehrJBJürgen Behr
- Claus NeurohrCNClaus Neurohr
- Gabriela LeuschnerGLGabriela Leuschner
Open Access
- 31 May 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (11) , 3787
Abstract
Physical activity limitations and cough are common in patients with interstitial lung disease (ILD), potentially leading to reduced health-related quality of life. We aimed to compare physical activity and cough between patients with subjective, progressive idiopathic pulmonary fibrosis (IPF) and fibrotic non-IPF ILD. In this prospective observational study, wrist accelerometers were worn for seven consecutive days to track steps per day (SPD). Cough was evaluated using a visual analog scale (VAScough) at baseline and weekly for six months. We included 35 patients (IPF: n = 13; non-IPF: n = 22; mean ± SD age 61.8 ± 10.8 years; FVC 65.3 ± 21.7% predicted). Baseline mean ± SD SPD was 5008 ± 4234, with no differences between IPF and non-IPF ILD. At baseline, cough was reported by 94.3% patients (mean ± SD VAScough 3.3 ± 2.6). Compared to non-IPF ILD, patients with IPF had significantly higher burden of cough (p = 0.020), and experienced a greater increase in cough over six months (p = 0.009). Patients who died or underwent lung transplantation (n = 5), had significantly lower SPD (p = 0.007) and higher VAScough (p = 0.047). Long-term follow up identified VAScough (HR: 1.387; 95%-CI 1.081–1.781; p = 0.010) and SPD (per 1000 SPD: HR 0.606; 95%-CI: 0.412–0.892; p = 0.011) as significant predictors for transplant-free survival. In conclusion, although activity didn’t differ between IPF and non-IPF ILD, cough burden was significantly greater in IPF. SPD and VAScough differed significantly in patients who subsequently experienced disease progression and were associated with long-term transplant-free survival, calling for better acknowledgement of both parameters in disease management.Keywords
Funding Information
- Boehringer Ingelheim (50/16)
- Friedrich-Baur-Stiftung (50/16)
- German Society “Lungenfibrose e.V” (50/16)
This publication has 33 references indexed in Scilit:
- Physical Activity Profile of Lung Transplant Candidates With Interstitial Lung DiseaseJournal of Cardiopulmonary Rehabilitation and Prevention, 2013
- The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaireThorax, 2012
- Objective cough frequency in Idiopathic Pulmonary FibrosisCough, 2010
- The SF-36 and SGRQ: Validity and first look at minimum important differences in IPFRespiratory Medicine, 2010
- Cross‐sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire in patients with IPFRespirology, 2008
- ERS guidelines on the assessment of coughEuropean Respiratory Journal, 2007
- Empfehlungen zur Diagnostik der exogen-allergischen AlveolitisPneumologie, 2007
- Cyclophosphamide versus Placebo in Scleroderma Lung DiseaseNew England Journal of Medicine, 2006
- A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory QuestionnaireAmerican Review of Respiratory Disease, 1992
- The St George's Respiratory QuestionnaireRespiratory Medicine, 1991